Xilio Therapeutics, Inc. (XLO) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-4.19 | +72.5% |
| 2024 | $-15.24 | -448.2% |
| 2023 | $-2.78 | +13.7% |
| 2022 | $-3.22 | +76.2% |
| 2021 | $-13.52 | +87.2% |
| 2020 | $-105.42 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-4.19 | +72.5% |
| 2024 | $-15.24 | -448.2% |
| 2023 | $-2.78 | +13.7% |
| 2022 | $-3.22 | +76.2% |
| 2021 | $-13.52 | +87.2% |
| 2020 | $-105.42 | — |